Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Rothe

Praxis

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Praxis|December 11, 2014
[Phenotype specific therapy of COPD]Thomas Rothe
Praxis|September 1, 2021
[Spirometry in the Medical Practice - Part 1: Measuring]Thomas Rothe
Praxis|September 29, 2021
[Spirometry in the Medical Practice - Part 2: Interpretation]Thomas Rothe
Praxis|June 17, 2025
[Asthma essentials for the practitioner]Thomas Rothe
Praxis|October 27, 2021
[Type-2 Asthma: Leaving Behind the Perspective of the Seventies]Thomas Rothe, Tsogyal Daniela Latshang
Praxis|September 16, 2020
[Physical and Clinical Aspects of Inhalation Therapy for Asthma and COPD]Thomas Rothe, Andrea Fronkova, Thomas Pein, et al.
Praxis|June 12, 2024
[New manifestation of a type 2-inflammation in the upper respiratory tract with nasal polyposis under treatment with an asthma biologic]Anita E Gander, Mona Leuenberger, Yves Brand, et al.
Praxis|May 29, 2019
[Benralizumab: Targeting the IL-5 Receptor in Severe Eosinophilic Asthma]Jörg D Leuppi, Peter Schmid-Grendelmeier, Thomas Rothe, et al.
Praxis|May 29, 2019
[Benralizumab: Targeting the IL-5 Receptor in Severe Eosinophilic Asthma]Jörg D Leuppi, Peter Schmid-Grendelmeier, Thomas Rothe, et al.
Praxis|October 27, 2021
[Novelties in the Treatment of Asthma]Jörg D Leuppi, Pierre-Olivier Bridevaux, Florian Charbonnier, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Praxis|December 11, 2014
[Phenotype specific therapy of COPD]Thomas Rothe
Praxis|September 1, 2021
[Spirometry in the Medical Practice - Part 1: Measuring]Thomas Rothe
Praxis|September 29, 2021
[Spirometry in the Medical Practice - Part 2: Interpretation]Thomas Rothe
Praxis|June 17, 2025
[Asthma essentials for the practitioner]Thomas Rothe
Praxis|October 27, 2021
[Type-2 Asthma: Leaving Behind the Perspective of the Seventies]Thomas Rothe, Tsogyal Daniela Latshang
Praxis|September 16, 2020
[Physical and Clinical Aspects of Inhalation Therapy for Asthma and COPD]Thomas Rothe, Andrea Fronkova, Thomas Pein, et al.
Praxis|June 12, 2024
[New manifestation of a type 2-inflammation in the upper respiratory tract with nasal polyposis under treatment with an asthma biologic]Anita E Gander, Mona Leuenberger, Yves Brand, et al.
Praxis|May 29, 2019
[Benralizumab: Targeting the IL-5 Receptor in Severe Eosinophilic Asthma]Jörg D Leuppi, Peter Schmid-Grendelmeier, Thomas Rothe, et al.
Praxis|May 29, 2019
[Benralizumab: Targeting the IL-5 Receptor in Severe Eosinophilic Asthma]Jörg D Leuppi, Peter Schmid-Grendelmeier, Thomas Rothe, et al.
Praxis|October 27, 2021
[Novelties in the Treatment of Asthma]Jörg D Leuppi, Pierre-Olivier Bridevaux, Florian Charbonnier, et al.
Pageof 2